CanSino Gets China First Covid-19 Vaccine Patient
Vials of a COVID-19 vaccine patient, a recombinant adenovirus vaccine named Ad5-nCoV, developed by Chinese biopharmaceutical firm CanSino Biologics Inc.…
Vials of a COVID-19 vaccine patient, a recombinant adenovirus vaccine named Ad5-nCoV, developed by Chinese biopharmaceutical firm CanSino Biologics Inc.…
On July 6th, CEO of AJM Pharma, Adnan Hussain, signed an MoU with CanSino Biologics INC (CanSinoBIO), a China-based vaccine…